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Colony-Sthnulating Factor Mediate Langerhans 
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It has been reported that the ill vivo maturation of 
Langerhans cells after hapten painting is mediated by 
IL-II3 while Langerhans celllnaturation after ill IIU,'O 
culture is mediated by granulocyte-macrophage col-
ony- stimulating factor (GM-CSF). To clarify the rea-
son for this discrepancy, we exanlined the expression 
ofIa antigen and several co-stitnulatory molecules on 
Langerhans cells that were activated by ill .fit,'o cul-
ture, by hapten painting, or by an intradermal injec-
tion of several cytokines. Both cultured Langerhans 
cells and those activated by hapten painting in-
creased the expression of la antigen and all the 
co-stimulatory molecules (i.e., intercellular adhesion 
molecule-I [ICAM-I], B7-I, B7-2, and CD40). In 
contrast, an intradermal injection of interleukin-113 
(IL-If3) or tumor necrosis factor-a (TNF-a) increased 
the expression of Ia antigen, ICAM-I, B7-2, and 
CD40, but not that ofB7-1. These data indicate that 
R ecentl y it ha s been demonstrated , by several authors [1. 2,1 4,23,24,29 J that Langerhan s cells can be m aturated both ill IIi"O and ill "ifro, Maturated Lange rhan s ce ll s in crease their expression of major histocompatibility co mplex (M HC) class II antigcn 
(Ag) and show en hanced antigcn prescnting fun ction [4.21 ,30]. 
W itmer- Pack cf 111 [32J and )-ieuAer ef III [1 3] have demonstrated 
that the maturati on of Langerhans cell s that occu rs after ill IIifm 
short-term culture is mediated by granulocytc-macrophagc colon y-
sti mulating factor (GM-CSF) and that inte rl cukin-1 (rL- l) en-
hances the e ffcct of GM- C SF. On the other hand, Enk cf 111 [10] 
havc fo und that the increase in Langcrhans cell-derivcd IL-1 f3 
mRNA signal strength is the first even t in the process of ill I, ill" 
maturation of Langerhans cells aftcr hapten painting . In addition, 
they showed that the cutaneou s inj ec tion of IL-1 f3 res ul ted in 
increased exp ress io n of M.H C class II Ag .. Ild en hanced antigen 
presenting fun ction by Langerhans ccll s suggesti ng that ill lIillo 
ma turation o f La ngerhans ce ll s th;lt occurs after hapten painting is 
mediated by I L-I f3 18]. T herefore, if Langerhans cell maturation 
induced by the cutan eous injection of IL-'l f3 is the sa me ph en om-
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IL-113 or TNF-a is not sufficient to induce B7- I 
expression on Langerhans cells ill .';110. Subsequently 
we examined the effect of anti-cytokine antibodies 
(Abs) on the expression of those molecules on cul-
tured Langerhans cells. While none of the Abs to 
IL-II3, TNF-a, or GM-CSF changed the upregulation 
ofla antigen, ICAM-I, or CD40 on cultured Langer-
hans cells, anti-GM-CSF Ab suppressed that of B7-I 
and B7-2. Taken together, our present results suggest 
that IL-113 is required for the upregulation of la, 
ICAM-I, B7-2, and CD40, while GM-CSF is required 
for the upregulation of B7-I and B7-2, although it 
still remains unclear why the injected GM-CSF could 
not augluent B7-I expression on Langerhau.s cells i71 
IIillo and why anti-IL-113 Ab did not suppress the 
upregulation of la, ICAM-I, or CD40 on cultured 
Langerhans cells. Key words: B71tllllJ.ol' IIec"'osis facto' .... al 
CD40Icl'tok;IIe. ] IIlIIest Demratol106:441-445, 1996 
en on as that occurring on Langerhans cells that mature after hapten 
painting, there remains a discrepancy in the reported beh avio r of 
cytolcines that mediate the m aturation of L1ngerhans cells between 
;11 pilll) and ill ";(1"0. 
It is also we l1 known that accessory molecul es are rcquired for 
antigen-presenting cells to stimulate T cell s 17,15,22,28,3 1]. T hcre-
fore, in this study examining the phenotypic changes in Langerhans 
cells maturated ill I/ifro aud ill II illO, we havc analyzed the contribu-
tion of diffe rent cytolcincs in the maturatio n process of Langerhans 
cell s unde r ill l,iv(I and ill IIifm situ ations. 
MATERJALS AN I METHODS 
M.iee Specifi c pathogen-fi'ee I" malc OAU3/c AJclmice. 8-10 wk of age. 
were obtaincd fro lll the Institute of Expcl;m ental Animals. Tohoku Uni-
ve rsity School of Mcdicine, 
Antibodies We uscd thc followi ng m onoclonal antiboo ies (MoAbs) for 
in1ll'11Inosta ining : anti-intcrcc llula r ad hes ion molecule-I (ICAM- I) (KA T-
I). anti-CD-IO (HM-40-3) (gifts fi'ol11 Dr. Yagita and Dr. Kato. Dcpartment 
of Iml11unology. Julltcndo University. Tokyo . Japan). aI10-U7-1 (07 I B01). 
<I nti-07-2 (GL- I) (PharMingell. Sail Diego. C Al, ano fluorcscein isothio-
cyanate (FITC)-conjugated anti-I-E (d. k haplotypcs) (l'hmMingen) 
MoAbs. Phycoe r),tltrin-conjugated ami-rilt IgG (TAGO, UlII'lingill1lc . CAl 
o r bioon ylatcd anti-hamster I ~G (Vcctor Labonn:ories. 13l11'linga m e. CAl 
followed by phycocrythrin -conjugated avidi n (Uecton-Dickinsoll. Sa il J ose. 
CAl wcre used as second-stcp rl'agcnts , Isotype-lI1atched ral control Ab 
(lgG 2• and IgG21,). halllste r IgG and FITC-colljuga ted rat control IgG oh Ab 
(PharMingcn) ,vere llsed <1 S negative contro ls. In o rd er to cxanlinc the 
clrccts of anti-cytokinc Abs 011 th e upreguiation of adhesion molecul es or 
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MH C class JI Ag by ill " itro cul tured Langerh"n s ce ll s, we used goat 
anti-murine GM-CSF, anti-murine tUl110r necrosis f.,cto r-CI' (TNF-a). and 
anti-1I1urine IL-1 {3 Ab frol11 R&D System (M inneapo li s. MN). Purifi ed Goat 
Ig was purchased frolll ZY MED Laboratories. Inc. (San Francisco. CAl. 
Chcmicals and Cytokincs 2.4 .6-trinitrochlo robcnzcnc (TNCB) was 
purchased from Tokyo Kase i Laborato ries (Tokyo, Japan) and was IHcpared 
in acetone/oli ve o il (1 :4) at 3% fi nal concentration. R.ecombi nan t murin e 
GM-CSF, recombinant murine TNF-CI' . and recombinant murine IL-1 (3 
wcre all obtained frol11 R &D Systcm. T hese cytokincs were suspen ded in 
phosphate-buffered salinc (PHS) containing 0.2'!!') bovine serum albumin 
(BSA). 
Chcmical Trcatmcnt and Cytolcinc Injcction After anesthetized 
with )I-hydroxybutyri c acid (Sigma Chemical Co .. St. Lo uis. MO) , BALB/c 
mice we re injected illtrade rmall y in each ear with 50 o r 250 Ilg of 
recombinant murine rG M-CSF, 50 ng of TNF-u, o r 50 ng of lL-1 {3. 
Another gro up of mice werc injected with PBS con ta ining 0.2% BSA as a 
negative control. As a positive control, other mice wcre pain ted on t h c ca rs 
with 3% TNCI3 in acctone/oLlve oil (1 :4) . In most experiments. epjdermal 
ce ll suspens ions wcre prepared 16 h after the treatmcnts. 
Preparation of Epidermal Cell Suspcnsion Epidermal cell suspen-
sions werc prepa red by treating the split skjn sheets of cars of nontrca ted o r 
chcrni caJl y treated mice, or those injected with va rio us cytokjnes with 1000 
U/ 1111 Dispase (Sanko Pure Chemical Inc., Tokyo, J apan) in RPMf-1640 
sup plemented w ith 1 % fetal bovine se rum fo r 2 h as described previo usly 
r3.19] . In order to ob tain a Langerhans cell- enrich ed population, these 
cpidcrmal cell suspensions were applied onto Lympho lite M density g radi-
en ts (Ccdarlane Laborato ri es Limited. Canada ) and centr ifuged at 1400 rpm 
fo r 10 111in nt roonl tel1lpCnlturc. T he in terface cell s were recovered. which 
contained 5-10'10 I-E-positive cell s (Lange rhans) in addition to keratino-
cytes. 
Langerhans Cell Culture R .. PMI 1640 medium supplemented with 10'X. 
fe tal bov ille serum , 2 mM glutamine (G ibco Laboratories . Chagrin Fa ll s, 
OH). penicillin. streptom ycin and fungizone antibiotic so lu tio n (Gibco) . 
non-essentia l amino acid so lution (G ibeo) . sodium pyruva te solution 
(Gibeo). 10 111M N-2-hydroxyethylpiperazine-N '-2-e thancsulfon.ic acid 
buffer solution (G ibco), 5 X 10- ' M 2-ME. and 1 p,g/ml indomethac in 
(Sigma) (complete medium) was used for the culture . Enriched Langerhans 
cell suspcns ions ( 1.5 X 10" / ml) were cultured in the complete m e dium 
using 24-well plate (Falcon) in the presence of goat Ig or MoAb to 
GM-CSF, TNF- CI' , o r I L- l {3. T he surface expression of various adhesion 
molecules oil Langerhans ccll s was exam ined by flo w cy tom etry 72 h aftc r 
culture. 
F low CytOJnetry For fl ow cytometry, cell suspensions were first incu-
bated with various MoAbs to mouse adhesion molecules o r isotype-matched 
rat or hamster control Abs fo r 30 min on icc, washed with PllS supp le-
m ented with 1% feta l bovine serum and 0.02% NaN , (washing buller) , and 
rhen incubated with ph ycoerythrin-conjuga ted anti-rar- Ig (TAGO). Or 
biotinylated an ti-hamste r IgG followcd by phycoerythrin-conjugate d av i-
d in. After being w"shed with washing buffer, ce lls were seriall y treated with 
50 /Lg/ml of rat Ig for 10 min and with FITe -I E o r FITC-rat control Ab for 
30 min on icc. Afte r being washed again, they werc ana lyzed On a FACSc:l n 
using Lysis " software (Becton Dickjnson) . LlI1gerhans cell s as identi fi ed by 
intense reacti vity with FITC-I:lbeled anti-I -E MoAb were gated for the 
analysis of MI-I C class " Ag or costimulatory molecule express ion. and 1110 re 
t han 3.000 events were acq uired for each ana lysis. Mean flu orescence 
intensity (MFI) was dctcrmined for e<l ch surface mo leculc. "nd the cll:ccts of 
cytokines were eva luated by percent<l ge M PI as c<llculatcd usin g the 
to llowing form ul a 15,6,171: 
% MFI 
( 
MPI of Langerh"ns cell streated with cytokj11l!(s) . T NCB. or Ab ) 
= MFI of Langerhans cell., treated with 0.2% I3 SA/PBS o r medium OJ11y 
X lOO'X, 
RESULTS 
Both Langerhans Cells after TNCB Painting and Those 
Cultured ill Vitro Could Upregulate the Expression of MHC 
Class II Ag, ICAM-l, B7-1 , B7-2, and CD40 We have 
reported that ilt lIillo maturated Langerhan s cell s in crease their 
ex press ion of MH C class II Ag togethe r with e nhan ced antigen 
presentin g func tion like Lan gerhans cells c ul ture d ill I'ilro [1]. 
Recen tly, culture d Langerhans cell s h ave been sh own to c nhan ce 
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F igure 1. Both Langerhans cells after TNCB painting and those 
cultured ill (Jitra lIpregulate the expression of MHC class nAg, 
ICAM-1, B7-1, B7-2, and CD40. Langerhans cell s maturated ill "illll br 
TNCB painting (n- e) and cultured Langerhans ce ll s (F-") were cxamined 
for the expression of MHC class " Ag (nJ), IC AM-1 (II,S), 137- 1 (t,") . J3D-2 
(d,i). and CD40 (ed) after gating I-E positive ce lls on FITC lIerSlI' side sca tter 
contour plo ts. T he profiles of Langerhans cell s maturated by TNCB 
painting and cultured Langerhans cd Is were indica ted by open histograms. 
and those representing fi'e shl y iso lated Langcrhans ce lls arc indica ted by 
shaded ones. 
their co- stimulatory molecules (e.g. , ICA M-l , B7-1) [21 ,30] . 
T h erefore, in this study we examined w hethe r Langerhans ceUs 
maturated ilt lI il lO afte r hapte n painting also upregulate those 
costimu lato ry m o lec ul es. Figure 1 presents representative da ta 
fi'om e ig h t different exp erim e n ts. N o ntreated fi'eshly iso la ted Lang-
e rhans cell s ex pressed MHC c lass II Ag, ICAM-I , 137- 2, and CD40, 
but did n ot e xpress B7-1. On the other hand , b oth cultured 
Langerhans cell s and t hose treated w ith TNCB painting ill Ii i 1'0 
sh owed upregulation of MHC cla ss ]( Ag, ICA M-l, B7-1, B7-2. 
and CD40 expression , alth o ug h the magnitude of th e e xpression of 
these molecules o n Langerhans cell s m aturated b y TNCB painting 
was mu ch less than that on culture d Langerhans cell s. 
The Intradermal Injection ofCytokines Could Not Upregu-
late B7-1 011 Langerhans Cells ill Vivo I L-1 f3 and G M-C SF are 
re po rte d to b e in volved in Lan gerhan s cellm3turatio n ill 1';1'0 and ill 
(lilro, resp ec tive ly [8, 13,32] . In addition , acco rding to E nk cI nl [8] . 
the cutaneou s injection of I L-l f3 induce th e phenotypic as well as 
functio n al maturatio n in Lan gerlwns cells ;11 (lhlo similar to that in 
th e se ceUs after h apten painting. We exam ine d thc express ion of 
MHC class II Ag, ICAM-l , B7-1 , B7- 2, and CD40 o n Langerhans 
cell s 16 h after intrad ermal injecti o n ofGM-CSF, T NF-a . o r lL- l{3, 
and compared their expressio n with those on Langerhans cell s after 
TNCB pain ting (Fig 2) . Lange rhans cell s from the mice injected 
w ith IL-1 f3 o r T NF-a enhan ced the e xpressio n of MHC class II Ag. 
!CAM-l. B7-2, and CD40 compared with those injected w ith 0.2% 
bovine serum a lbumin in PBS as contro l, w hil e no significant 
cha n ges w e re recogniza bl e o n th e ir expressio n ofB7-1. Intradermal 
inj ection of G M-CSF in two diffe re nt doses, e ithe r 50 or 250 
n gl ear, cou ld n ot affect tl1e express io n on Langerhans ce ll s of a\l the 
molec ul es we studie d. Furthermore, we perfo rmed a kjnetic study 
in which we prepared epide rm al ce ll su spe n sio n s at th e va rio us time 
inte rval s (i.e., 1,4,8, 16, and 48 h) after G M-CSF, IL-1 f3 injection , 
or TNCB treatment (Fig 3). We found that th e m ost re markable 
phenotypic changes o n Langerhans ceUs w e re observ ed at 16 h afte r 
the trea tm ents and that the ph en otype o f Lange rhan s ce ll s after 
G M-CSF injec tion was not diffe rent from that after PBS injec tion at 
each t ime point. R ecently, Kampgen et nl l1 6] have re po rted that 
IL-l induces G M-CSF receptor expressio n o n Langerhans ceLI s. 
T herefo re, it is con ceiva bl e th at the si mple inj ec tion of GM-CSF 
cannot affect th e ph en otypes of Langerhans ce ll s because of insuf-
fici ent numbers of expressed G M-CS F recepto rs o n fresh ly iso lated 
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Figure 2, The intradermal injection of cytokines cannot upregu-
late B7-1 on Langerhalls cells ill I';VO, Langerhall s cell s treated by the 
intradermal injection of G M-CSF, T N F-a, Il- l13, or by T N CB painting 
were examined for the expressio n of MHC class II Ag (a), ICAM-l (b), 
B7- 1 (c), B7-2 (d), and CD40 (e) after gating I-E-pos it ive cell s on FITC 
versus side scatter contour plots. M FI was determined for each surface 
molecule, and the effects of cytokines were eva luated by percentage MI' I as 
calculated using the fo llowing formula: 
% MFl 
_ (MFI of Langerhans cells treated w ith cytokine(s) o r TNCB) 
X 100'Y., 
MFI of Lange rh ans cells trented with 0.2% BSA/ PBS 
Langerhalls cells. To exclude such a poss ibility, we injected at first 
IL-l,8, and at diffe rent time intervals (0, 4, 8, 16 h) thereafter we 
examined the effect of GM-CSF; however, these combined injec-
tions did not alter the effects of injectin g lL-1,8 alone (data not 
shown). 
The Upregulation ofB7-1 Expression on Cultured Langer-
hans Cells Was Downregulated by Anti-GM-CSF Ab and 
Anti-TNF-a Ab From ill 11;'10 study, we could not specifY the 
cytokine(s) that mediate B7-1 upregulation . Thus, we examin ed 
the effects of Abs to several cytokin es on the upregul ation ofB7-1 , 
MHC class II Ag, and other accessory molecules on Langerhans 
cells cultured for 72 h (Fig 4). When we added 20 /-Lg/ml of 
anti-GM-CSF or anti-TNF-a Ab to the cul ture of epidermal cells, 
the expression ofB7-1 on Langerhans cells was inhibited , whereas 
the addition o f 20 /-Lg/ml of anti-IL-1,8 Ab could not suppress its 
expression a t all. In addition, only anti-G M-CSF Ab exerted a 
partial inhibito ,-y effect on the upregulation of B7-2 expressio n. 
Non e of the Abs to GM-CSF, TNF- a, or IL-l,8 changed the 
expression of MHC class II Ag, lCAM-l, o r CD40. 
DISCUSSION 
In tius study, we have demonstrated that Langerhans cells m atu-
rated ill lIillo by hapten painting also upregulate the co-stimulato ry 
molecules as well as MHC class II Ag. In other words, Langerhans 
cells that mature ill v ivo seem to b e almost identical with those that 
mature ill lIill'O, although the latter express the co- stimulatory 
molecules much more than the former. 
We did demonstrate that the phenotype of Langer hans cells after 
intradermal injection ofIL-1,B was diffe rent from that of Langer hans 
cells after hapten painting. Langerhans ce LIs o btained after intra-
dermal injection of IL-l,8 did not upregulate B7-1, whereas ;11 11 ;110 
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Figure 3_ The kineti c studies of the expression of MHC class II Ag 
and co-stimula tory molecules after injection of various cytokines_ 
Prc pnri n g cpidc nna.l cell slI spensio 11 were started at va riou s cinlcs (c.g .. ]. 4 , 
8, 16, o r 48 h) afte r GM-CSF (---). l L-I13 (-) injecti o n. or TNCB (_) 
trcatnlCl1t. Treated Langerhans cells were cxanlincd for the expression of 
MH C class II Ag (6 ) . ICAM- 'I (0 ), and B7- 1 (0 ) after gating l-E-positive 
cell s o n PITC lIerslls side scatter co ntour plots. T he exprcssion ofB7-1 o n 
La ngerhans ce lls was not different fi'om that of 0.2% BSA/ PBS injection as 
a negative con tro l at all time po int aftcr GM-CSF injection. indicating that 
intradem,al injection of GM-CSF had not m ade La nge rh"ns cells left fro m 
the epidermis at 16 h aftcr injection. In .. ddition. the upregulatio n of M H C 
class II Ag and ICA M-l after IL- t 13 injection o r TNCB trea tmcnt had 
started at 4 h and beca rn e Illost marked '16 h after treatlllen ts respectively. 
hapten treatm en t definite ly increased 137-1. This observed differ-
en ce indicates that the si mpl e inj ec tion of IL-l (3 could not be a 
substitute for the m ed iato rs in vo lved in L:lJ1gerh ans cell maturation 
after h apten painting and th at other signals arc required for the full 
simulation of Langerhans cells. T herefore, we next examined 
whether TNF-a or GM- CSF, which were suggested to affect 
Langerhans cell fun ction ill 'Iil ro 1' 13, 18,32), a uld upreglllate the 
expressio n of B7-1.. Unexpectedly, we could not recogni ze the 
upregulatio n ofB7-1 expression either by the in tradermal injection 
of 50 o r 250 ng/ea r of GM-CSF, o r by th at of T NF-a. 
O n the other hand , anti-GM-CSF Ab and , altho ugh less effi-
ciently , anti-TNF-a Ab could suppress the llpregulation of137-1. on 
cultured Lan gerhans cells, sugges ting that G M-CSF an d T N F-a 
mediate the in crease in expressioll of 137-1 on Langerhans cell s ill 
vitro . These ill "i llO and ill II il l'O data suggest that Langerhans ceUs 
require both IL-l,8 and GM-CSF for their fu ll maturation; the 
former is responsible for the llpregllla tio n of MHC class II Ag, 
ICAM-l, 137-2, and CD40, w hik the latter is fo r that of 137-1 . 
When we assume, however, that GM- CSf upregllJate th e ex-
press ion ofB7-1 , w hj le LL-l ,8 increase the e xpression of MHC class 
II Ag, (CAM-I , 137- 2, and CD40, at least two qu es tions ari se. The 
first is w hy we could not recognize the upregulatio n ofB7-1 afte r 
GM-CS,F il'jection. We can think of three possible explanations. 
T he first o ne is that the amount ofGM-CSF we inj ected is too small 
to induce the phe notypic changes of La nger hails ce lls. To excl ude 
this possibility, w e measured GM-CSF concen tration of the culture 
superna ta nt of epidermal cells , in w hich B7-1 upreguJation on 
Langerhans cells was induced . T he avera ge GM- CSF con centration 
in repeated experimen ts ranged fi-om 400 to 500 pg/ ml (data not 
shown), w hereas we injected 1 o r 5 /-Lg / ml, far exceeding amounts 
ofGM-CSF in OUl' experiments. T he second possible explanation is 
that GM-CSF actuall y cann ot reach o r bind th e receptors on 
epiderm al Lan gerhans cells. It is well known that g lycosaminogly-
ca ns bind to GM-CSF [11 ,25]. The glycosa rnin oglycan that is 
abundantly presen t in the dermis as well as at the de rm o-epidermal 
junction may bind to GM-CSF to inhibit its further difli.lsioll to 
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Figure 4. B7-1 e" pression on cultured Langer-hans cells is dOWJJ-
regula ted b y anti-GM-CSF Ab and anti-TNF-a Ab. C ultured Lang-
erhall s cells trea ted by anti-GM-CS F A b, anti-T N F-a Ab or 311 0-I L- 1 J3 Ab 
were examined fo r the expression of MH C class II Ag (11) , ICA M - l ( II ), and 
B7-·\ (c), B 7-2 (d) and C D 40 (r) after ga ting \-E posit ive c ells On FITC " C/"S IIS 
side .,catter conto ur plo ts. MFI W<lS determined for each surface m o lecul e. 
and the e/fects of cytokines were cv,dllated by percentage MF I as calculated 
using the fo llowing fo rmula: 
( 
MFI o fLallge rhallS cell s trc<lted wi th A b ) 
";., M PI = X 100% 
M FI of Lall gc rhallS cell s treated wieh m edium only 
epidermal La ngerhans cells . T h e third p ossibili ty is that SOlUe 
facto r(s) may exist in the dermis whi ch inhibi ts the ;11 11;110 m atur;l-
ti on ofLaligerhan s cells indu ced by G M-C SF injection. Streil e in ef 
ai' re po rted th at the conve rsio n of fi'eshly isolated to elrl tured 
Langerhans cells ill vit ro fails to occur if normal mo u se serum is 
presen t in the culturc fluid . We also think that the presen ce o f such 
a f,lcto r m ay explain wh y intradermal injectio n of GM-CSF fails to 
induce the ph eno typi c changes . 
R ecently, G rabbe ei a/ [1 2 J dc mon stra ted d efici e nt antigen-
presen ting cirpacity of Langerhans cell s isolated fTo m athyn1ie 
(1/1/ 11/1/) mice. In addition, they fo und that prein cubatio n o f th ese 
Lange rhans cell s with G M-CSF reconstituted allo antigen-presel1t-
ing fun ctio n. W e speculated th at if G M-CSF wa s resp o nsible fo r 
137-1 upregul ati on on Langel'hans cells, 137-1 upregulatio n on 
Lan ger/w lls cells afccr T N CB pain ting should b e d ecreased in 
athymic (1111 / 111') mice . W e fo und that La n gerhans cell s fi'om 
athymi c ("II / II") mi ce showed signifi cantl y decreased upregularion 
o f 137-1 afte r TNC 13 painting when compare d wi th those fi 'om 
c uth ymic controls (/1,, /+ or + / + ), wh ere as th e upregulation of 
MHC class Il Ag, IC AM-I , ill1d C D40 exprcss ion in LangeThan s 
cell s wa s not significantly diffe rent amon g t hese anima ls (dara not 
shown) . T hese data al so suggest tha t the incr'cased ex press io n o f 
MH C class II Ag. l C AM-1 , and C D 40 on Langerha.n s cells afte r 
hapten paintin g is media ted b y a stimulation pathway diffe rent fro rn 
that required fo r the upregulat.ion o f1l 7-1 and tha t Langerhans cells 
fro m athymic mi ce are defec ti ve o nly in the la tte r pathway . 
T he second questio n is w hy ant i-IL-1 (3 Ab co uld n o t s uppress th e 
upl'egula tion of MH C class II Ag, IC AM-l . D7-2, 0 )· C D 40 on 
cultured Langerhans cells. Witmer-Pack ('/ ((I [3 2] re ported tha t the 
additi on of l1--1 alo ne to the highly purified L1l1 gerhan s cell culture 
I Strcilcin JW , X ic Y: A scrum ractor(s) that governs fl.lnc ti o nal propcr-
ti c.~ of epidermal Lang crhans cell s. ) 1Il11es/ D erllla/o/ 104:567, 1995 (abstr.) 
T H E J OU R NAL 0 1' IN VESTIGATIVE DErlMAT LOGY 
co uld n o t enhan ce th eir an tigen-presenting func tio n . H euRer CI ll/ 
[1 3] de monstrated that none o f anti-cytoki ne Abs coul d suppress 
t h e llpreglllati on of MH C class II Ag tha t occurs on cultu red 
L ange rh ans cells. O m' presellt observation is consistent w ith these 
d ata. but it is \lo t proper to judge that lL-1f3 is no t: in volved in the 
upregula tion of MH C class II Ag, ICA M-I . 137-2, o r C D40 in 
c u.lttll'ed Langerhans cells only ba sed on these findings. Enk d II / [9] 
h a ve fo und that increased IL-l{3 mRNA signa l is acc lImuloted in 
Langerhans ce lls as earl y as '/ 5 min ;rfce r exposure to contact 
a lle rgens. T h erefore , it is speculolted that the production of lL- lf3 
a lso starts in Langerh ans cells at an extrem ely earl y stage in culture . 
It took about 3 h fo r us to prepare Langerhans ce ll- enriched 
popula tio n and to sta rt their culture with anti-IL-l {3 Ab. T hus, "'~ 
c annot exclude the possibility that durin g this timc in terval. 
La ngerhans cells aI'e already stimula ted to increase MHC class II 
Ag, IC AM.-1 , 11 7- 2. and C D 40 express ion . 
As fo r the I'egulation of D7- 2 express io ll, we found that anri-
G M-CS F Ab slightly bu t clearly inhibi ted its augmentatio n in o ur ill 
Il itm culture study of Lan gerhans cells . larsen C( II/ [2()] recently 
d e m onstra ted that Langcrh ans cells frol11 cultures containing anti-
G M-C SF expressed decreased level s of CTLA-4-co unter receptor 
a nd tha t GM-CS F added in th e culture ca n upl'egulate the expres-
sion of both D7-1. and B7-2 0 \1 splenic dendriric ceJJ s. T hese data 
s ugges t tb at GM-CS F regula te bo th 137-1 and B7-2 expression of 
d endritic cells including Langerhans celJs. 
O ur present experiments showed that the intradermal injection 
o f T NF-a increased the expression o fMH C class 11 Ag, rCA M-i . 
B7-2, and C D 40 . and that ;lnti-T N F-a Ab suppressed the upregu-
la tio n of B7-1 on c u.l tured Langerhans cells. R ecently, Sallusto el II/ 
[26J have also dem o nstrated that T NF-a increased the ex press ion 
o f MHC class IT Ag, rC AM-l, and B7-l o n human dendritic cells 
that w ere obtained by the cu lture o f periphera l blood t1l ononu clear 
cells w ith GM-C SF and lL-4 . T NF-a also playa rol e in L111gerhans 
ce ll maturatio n w hich is distinc t from that of IL-l f3 and G M-CSF. 
Human Langerhans cells, which a re po tent an tigen-prcsenri11g 
cells in the skin. have been shown to express C D40 [23 ]. It has nor 
yet been rep orted , however , w h ether murine Lan gerhans cells 
express C D40 o r w hether they upregul ate it wh en they becorne 
n1ature ill "i"" or ill IIi/l'o. In this ex pe riment, we de m o nstrated rhar 
nlurin e tj'eshl y isola ted Langerh ans cells al so ex press C D 40 mole-
c l1l e and they upregulate C D40 during [II "ilro culture o r after 
h a pten painting . Th e express ion of C D 40 on Langerhans cells may 
play a c rucia l role in the ir antigen presentation. 
Finally, becau se we did not exam ine th e produ ctio n o f other 
c)' tokines after the injec tion of IL-l (3 , T NF- a, or G M-CSF, we 
could n o t comple tely exclude th e p ossibiljty th,lt the cytokines 
induced by IL-l {3 injection m ;lY aflect the pl1 enotypic changcs on 
La ngerhan s cells ill IIi llo . 
T bis sllIdy /lias slIp/", rled by Crall/s·il/ -A id ji". Scierrli/ir n Nl'flld, 06 -15 -1JIJ "ml 
0 7670929 Ji·o", (he M;lIisII1' ~r Ed"f", ;"" ,)"!,"", " li d ('Y 1(, 1' Nn /w llI/"i FII/ II ,dll(ioll. 
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